iAspirants
Current AffairsPrelims PYQsUPSC CSE SyllabusUPSC CSE StrategyBlogsPricing
Login
iAspirants

Your AI-powered companion for UPSC preparation.

Quick Links

  • Home
  • About Us
  • Current Affairs
  • Prelims PYQs
  • UPSC CSE Syllabus
  • UPSC CSE Strategy
  • Blogs

Company

  • Pricing
  • FAQs
  • Contact Us
  • Login

Legal

  • Privacy Policy
  • Terms & Conditions
  • Return Policy

© 2025 iAspirants, Inc. All rights reserved.

  1. Blogs
  2. Economic and Social Development

Global Tuberculosis Report 2025 Highlights

Published on: 16-Nov-2025

Share this post

Global Tuberculosis Report 2025 Highlights

Article Summary

Summary of WHO Global Tuberculosis Report 2025

Key Statistics and Facts:

  • Global TB Incidence: In 2024, TB affected approximately 1.07 crore individuals worldwide, leading to over 12 lakh deaths.
  • Concentration of Cases: 87% of TB patients were from 30 countries, notably India (25%), Indonesia (10%), and the Philippines (6.8%).
  • India's Progress: India experienced a 21% decrease in TB incidence from 237 to 187 per lakh population from 2015 to 2024, nearly doubling the global decline rate. Treatment coverage reached 92%.

Regional Data:

  • The highest TB cases in India were in:
    • Uttar Pradesh
    • Maharashtra
    • Bihar
    • Madhya Pradesh
  • Delhi has the highest TB prevalence rate.

Government Initiatives:

  • Revised National Tuberculosis Control Programme renamed to National TB Elimination Programme (NTEP) aims at TB elimination by 2025, ahead of the global target of 2030.
  • The government has expanded the TB laboratory network to 9,391 rapid molecular testing units and 107 culture testing labs.
  • Introduction of AI-enabled X-ray units for enhanced community screening, with over 500 units deployed and an addition of 1,500 planned.
  • Nutritional Support: Under Ni-kshay Poshan Yojana, monthly benefits for TB patients increased from ₹500 to ₹1,000.

Challenges:

  • Persistent drug-resistant TB, inadequate healthcare infrastructure in rural regions, and socioeconomic disparities hinder access to treatment.
  • Funding issues: Global TB funding was stagnant, with only $5.9 billion available in 2024, significantly below the $22 billion target needed by 2027.

Global Trends:

  • From 2023 to 2024, global TB illness rates decreased by 2%, and deaths fell by 3%.
  • Since 2000, timely treatment of TB has reportedly saved 8.3 crore lives.
  • Development in TB research: Currently, 63 diagnostic tests and 29 drugs are in clinical trials, with 18 vaccine candidates under development.

Constitutional Context and Health Policies:

  • The report highlights the implementation of health initiatives in line with Directive Principles of State Policy (DPSPs) aimed at promoting public health.
  • The government's ongoing strategies align with the constitutional mandate to ensure the right to health.

This report signifies the need for sustained efforts, adequate funding, and emphasis on reducing stigma to achieve TB eradication goals effectively.

Key Terms & Concepts

World Health Organization (WHO)Reported Global TB statistics
12 lakhTB deaths in 2024
1.07 croreTB patients estimated in 2024
National TB Elimination Programme (NTEP)India's TB control initiative
₹1,000DBT amount under Ni-kshay Poshan Yojana
92%TB treatment coverage in India
5.9 billionGlobal TB funding in 2024
22 billionAnnual funding target for TB by 2027
8.3 croreLives saved from TB since 2000
9,391TB rapid testing facilities in India
1.78 lakhAyushman Arogya Mandirs in India
18Vaccine candidates in clinical trials
63

Mind Map for UPSC Civil Services Revision

Turn UPSC Civil Services Current Affairs Into Exam-Ready Notes

Reading Economic and Social Development current affairs is half the work. Revise them with ready-made notes and test what actually stuck.

  • Daily UPSC Civil Services current affairs analysis
  • Revision notes, mind maps & MCQs
  • Prelims mock tests with instant results

Related UPSC Civil Services Current Affairs Articles

Tata Sons Faces Leadership Challenges
Economic and Social Development20-Sep-2026

Tata Sons Faces Leadership Challenges

Tata Sons Pvt. Ltd. Overview

Establishment and Structure:

  • Established in December 1917; transitioned from public company to private in 2017.
  • Headquarters: Bombay House, South Mumbai.
  • Governed by a Board of Directors led by (executive chairman).
Diagnostic tests in development
29Drugs in clinical trials
2020Funding stagnated for TB
2%Decline in global TB illness rate
3%Decrease in TB deaths globally
500AI-enabled hand-held X-ray units
N. Chandrasekaran

Ownership:

  • Majority owned (66%) by Tata Trusts, which are philanthropic entities established from Tata family contributions.
  • Other shareholders: Shapoorji Pallonji Group (18%), Tata Group companies (13%), individuals (3%) mainly from the Tata family.

Financial Performance (FY2026):

  • Standalone profit: ₹31,961 crore (up 22% YoY).
  • Revenue: ₹42,367 crore (up 9.1% YoY).
  • Consolidated revenue: ₹16.24 lakh crore; profit rose 52% to ₹1.71 lakh crore.

Distinct Business Model:

  • Operates independently managed companies, including TCS, Tata Steel, Tata Motors, and more, reflecting a unique mix of philanthropy and business.

Current Issues Facing Tata Sons

Leadership and Governance Disputes:

  • Conflict regarding the re-appointment of N. Chandrasekaran as executive chairman for a third term starting February 2027.
  • Tata Trusts’ chairman Noel Tata opposes the re-appointment and has raised governance concerns.
  • Majority shareholder Tata Trusts seeks to keep Tata Sons private due to philanthropic goals, contrary to the board's preference for compliance with regulatory mandates.

Regulatory Developments

RBI Decision (September 11, 2026):

  • Rejected Tata Sons' application for voluntary surrender of its Certificate of Registration to be classified as an unregistered Core Investment Company (CIC).
  • Directed compliance with regulations applicable to upper-layer non-banking finance companies (NBFCs), implying mandatory stock exchange listing.
  • This regulatory decision has intensified tensions within the board and Tata Trusts over governance and operational independence.

Historical Context

Past Conflicts:

  • Echoes the 2016 boardroom battle leading to the ousting of then chairman Cyrus Mistry, where significant influence was maintained by Ratan Tata.
  • The current scenario mirrors past disputes, suggesting a potential for legal battles between a majority stakeholder and the governing board.

Future Implications

Ownership Model and Philanthropy:

  • Ongoing disputes raise concerns about the survival of Tata's unique ownership model that combines commercial and philanthropic interests.
  • The outcome of these conflicts may redefine Tata Sons' operational structure and strategic direction in the competitive landscape.

Key Takeaways

  • Significant dichotomy in priorities between the board and majority shareholders.
  • Critical regulatory decisions may push Tata Sons towards becoming publicly listed, contradicting traditional practices tied with philanthropic integrity.
  • The resolution of ongoing conflicts will shape the future trajectory of Tata Sons and its affiliated enterprises.
Punjab's Struggle Against Drug Addiction
Economic and Social Development19-Sep-2026

Punjab's Struggle Against Drug Addiction

Summary of Key Points Related to Addiction and Governance in Punjab

Addiction Context in Punjab

  • Over 1 million individuals registered at government de-addiction clinics in Punjab.
  • Historical context: Afeem (opium) and its cultural use have been prevalent for over 200 years; substance use has deep roots in community traditions.

Nature of Addiction

  • Opioids (e.g., opium, heroin) affect brain receptors; heroin leads to quicker addiction compared to opium due to its rapid impact on the body.
  • Addiction is often misunderstood; treatment requires more than willpower—it's a complex biological condition influenced by substance chemistry.

Urgency and Governance in Addressing Addiction

  • Governance failure: Current measures have not broken existing drug supply networks.
  • Technological measures: Recommendations for border control include:
    • Detection grids
    • Counter-drone systems
    • Improved forensic capabilities to trace drug origins

Budget and Resource Allocation

  • The funding directed towards de-addiction programs in Punjab is inadequate:
    • The entire budget for de-addiction is described as a "rounding error" relative to other priority areas (e.g., power subsidy).
    • There is a lack of specialists: Punjab has a deficit of psychiatrists and counselors.

Economic and Employment Factors

  • An emphasis on providing jobs for recovering addicts to prevent relapse.
  • Cost of medication (30 Rupees health clinic vs. 300 Rupees on the black market) demonstrates a disparity that indicates a lack of regulation and support.

Recovery Potential

  • Addiction recovery is possible; the brain can heal, albeit slowly.
  • Continuous support and medical assistance post-recovery are critical, with noted high relapse rates occurring 18 months after treatment.

Conclusions and Recommendations

  • The issue of addiction is framed as a medical condition compounded by a criminal supply chain and requires focused governance.
  • Importance of prioritizing investments in mental health treatment and de-addiction services in Punjab to curb the crisis.

This summary provides an analytical view of the addiction situation in Punjab, highlighting the need for substantial reforms, resource allocation, and a shift in societal understanding of addiction as a medical rather than purely moral crisis.

Continuation of PM-KISAN Scheme Approved
Economic and Social Development18-Sep-2026

Continuation of PM-KISAN Scheme Approved

Summary of the Pradhan Mantri Kisan Samman Nidhi (PM-KISAN) Scheme

  1. Scheme Approval:

    • The Union Cabinet has approved the continuation of the PM-KISAN Scheme for the period from 2026–27 to 2030–31.
  2. Financial Outlay:

    • Total financial outlay for the extended period is ₹3.15 lakh crore.
  3. Assistance Amount:

    • Each eligible farmer receives ₹6,000 per year as financial assistance.
  4. Direct Transfers:

    • Over ₹4.47 lakh crore transferred directly to farmers' bank accounts in 23 instalments since the scheme's launch in February 2019.
  5. Beneficiaries:

    • Under the 23rd instalment, over 9.49 crore farmers benefited, with ₹18,984 crore released.
    • Approximately one-quarter of beneficiaries are women farmers, who have received more than ₹1.06 lakh crore.
  6. Objectives of the Scheme:

    • Aims to provide timely and transparent income support to eligible farmer families through the Direct Benefit Transfer (DBT) system.
    • Encourages farmers to invest in agricultural inputs such as seeds, fertilizers, irrigation, and machinery.
    • Helps reduce dependence on informal credit and enhances the financial stability of rural households.
  7. Government's Commitment:

    • The continuation of PM-KISAN underlines the government’s belief that the prosperity of farmers is central to national prosperity.
  8. Impact on Agricultural Investment:

    • The assistance has reportedly enabled farmers to make timely investments in agriculture, thereby increasing their productive capacity.

This structured approach by the government aims at reinforcing the socio-economic condition of the agricultural sector, showcasing the significance of structured financial support for farmers in India.